GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,066,220 | -0.3% | 2,659,944 | +19.6% | 0.03% | +4.0% |
| Q2 2023 | $132,465,306 | -14.6% | 2,224,812 | -18.8% | 0.02% | -19.4% |
| Q1 2023 | $155,119,402 | -37.7% | 2,738,690 | -18.3% | 0.03% | -38.0% |
| Q4 2022 | $248,954,823 | +14.5% | 3,352,024 | -8.2% | 0.05% | +8.7% |
| Q3 2022 | $217,419,000 | +12.2% | 3,649,825 | +5.7% | 0.05% | +17.9% |
| Q2 2022 | $193,779,000 | -18.9% | 3,451,721 | +6.6% | 0.04% | -4.9% |
| Q1 2022 | $238,796,000 | +2.8% | 3,236,599 | +0.6% | 0.04% | +10.8% |
| Q4 2021 | $232,211,000 | -6.6% | 3,216,224 | -0.9% | 0.04% | -11.9% |
| Q3 2021 | $248,608,000 | -17.9% | 3,244,691 | -16.9% | 0.04% | -16.0% |
| Q2 2021 | $302,902,000 | +35.9% | 3,906,909 | +8.1% | 0.05% | +28.2% |
| Q1 2021 | $222,879,000 | -18.8% | 3,614,076 | -14.1% | 0.04% | -23.5% |
| Q4 2020 | $274,326,000 | +25.7% | 4,206,162 | -4.5% | 0.05% | +13.3% |
| Q3 2020 | $218,218,000 | +19.8% | 4,406,664 | +15.5% | 0.04% | +9.8% |
| Q2 2020 | $182,105,000 | +13.3% | 3,816,919 | +1.0% | 0.04% | -4.7% |
| Q1 2020 | $160,705,000 | -28.6% | 3,778,644 | -1.1% | 0.04% | -8.5% |
| Q4 2019 | $224,936,000 | +10.9% | 3,820,232 | -3.7% | 0.05% | +2.2% |
| Q3 2019 | $202,800,000 | +9.8% | 3,967,140 | -9.1% | 0.05% | +12.2% |
| Q2 2019 | $184,671,000 | -27.0% | 4,365,751 | -14.7% | 0.04% | -28.1% |
| Q1 2019 | $252,975,000 | +12.2% | 5,119,909 | -1.7% | 0.06% | +1.8% |
| Q4 2018 | $225,439,000 | -21.6% | 5,208,829 | +2.9% | 0.06% | -8.2% |
| Q3 2018 | $287,401,000 | -0.5% | 5,063,444 | -11.5% | 0.06% | -4.7% |
| Q2 2018 | $288,765,000 | -14.6% | 5,722,657 | -15.7% | 0.06% | -15.8% |
| Q1 2018 | $338,012,000 | +22.7% | 6,784,641 | +1.2% | 0.08% | +24.6% |
| Q4 2017 | $275,536,000 | +36.8% | 6,704,063 | -1.1% | 0.06% | +32.6% |
| Q3 2017 | $201,448,000 | +14.0% | 6,778,200 | +27.2% | 0.05% | +9.5% |
| Q2 2017 | $176,646,000 | -11.4% | 5,328,635 | -20.9% | 0.04% | -12.5% |
| Q1 2017 | $199,438,000 | +5.4% | 6,733,189 | -11.7% | 0.05% | +2.1% |
| Q4 2016 | $189,246,000 | -3.0% | 7,627,761 | -11.8% | 0.05% | -4.1% |
| Q3 2016 | $195,123,000 | +9.2% | 8,645,199 | +15.3% | 0.05% | +6.5% |
| Q2 2016 | $178,676,000 | -0.5% | 7,497,991 | -0.8% | 0.05% | -2.1% |
| Q1 2016 | $179,601,000 | -10.5% | 7,562,120 | +4.9% | 0.05% | -9.6% |
| Q4 2015 | $200,571,000 | +50.2% | 7,209,558 | +11.5% | 0.05% | +40.5% |
| Q3 2015 | $133,575,000 | -18.2% | 6,465,411 | +1.6% | 0.04% | -11.9% |
| Q2 2015 | $163,342,000 | +18.3% | 6,363,158 | +16.3% | 0.04% | +16.7% |
| Q1 2015 | $138,111,000 | +21.9% | 5,471,885 | +14.8% | 0.04% | +20.0% |
| Q4 2014 | $113,315,000 | +10.6% | 4,767,143 | -8.4% | 0.03% | +7.1% |
| Q3 2014 | $102,409,000 | -19.2% | 5,206,341 | -1.7% | 0.03% | -17.6% |
| Q2 2014 | $126,671,000 | -17.1% | 5,295,599 | -7.9% | 0.03% | -19.0% |
| Q1 2014 | $152,845,000 | +29.3% | 5,748,233 | -1.9% | 0.04% | +23.5% |
| Q4 2013 | $118,216,000 | +18.6% | 5,858,059 | +2.6% | 0.03% | +9.7% |
| Q3 2013 | $99,647,000 | +91.4% | 5,707,185 | +84.8% | 0.03% | +82.4% |
| Q2 2013 | $52,055,000 | – | 3,087,511 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |